Research programme: human monoclonal antibodies - VaccinogenAlternative Names: Oncavert®
Latest Information Update: 23 Jun 2016
At a glance
- Originator Vaccinogen
- Class Antibodies; Monoclonal antibodies
- Mechanism of Action Immunomodulators; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research Adenocarcinoma